Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2024Frontiers in ImmunologyOpen Access

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

CLColton LadburyCity Of Hope National Medical CenterCHClaire HaoJohns Hopkins UniversityWWWilliam T. WatkinsCity Of Hope National Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ladbury et al. (2024) studied this question.

synapsesocial.com/papers/68e56113e2b3180350efdbc0https://doi.org/10.3389/fimmu.2024.1419788
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma2023 · 33 citations
  2. 2Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?2021 · 63 citations
  3. 3The technical design and concept of a PET/CT linac for biology-guided radiotherapy2021 · 90 citations
  4. 4Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma2018 · 157 citations